WFA of San Diego’s Avita Medical RCEL Stock Holding History

WFA of San Diego’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,000	Closed	-$6.6K	–	341
2022 Q4	$6.6K	Buy	+1,000	New	+$5.99K	0.01%	389

Other funds holding RCEL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

WFA of San Diego's RCEL Position: Q1 2023 in Review

WFA of San Diego sold out of Avita Medical (RCEL) in Q1 2023, closing a stake of 1,000 shares — an estimated $6.6K sold.

WFA of San Diego first reported a position in RCEL in Q4 2022 and held it in 1 quarter. The position peaked at $6.6K in Q4 2022. 71 funds tracked by Wall St. Rank hold RCEL as of Q1 2023.

WFA of San Diego reported no remaining Avita Medical position as of Q1 2023 after selling out during the quarter.
WFA of San Diego sold 1,000 Avita Medical shares in Q1 2023, an estimated $6.6K.
WFA of San Diego first reported a position in Avita Medical in Q4 2022 and held it in 1 quarter.
WFA of San Diego's Avita Medical position peaked at $6.6K in Q4 2022.
71 funds tracked by Wall St. Rank held Avita Medical as of Q1 2023.

Based on WFA of San Diego's 13F filing for Q1 2023, filed 17 Apr 2023.